Quest Diagnostics Inc (NYSE:DGX)
$ 153.02 -0.4 (-0.26%) Market Cap: 17.08 Bil Enterprise Value: 23.40 Bil PE Ratio: 20.57 PB Ratio: 2.52 GF Score: 86/100

Quest Diagnostics Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 03, 2021 / 12:00PM GMT
Release Date Price: $128.14 (+0.48%)
Brian Gil Tanquilut;Stock Analyst
Jefferies LLC, Research Division - Senior Equity

/

Good morning, and welcome to the 2021 Jefferies Global Healthcare Conference. It's day 3 of the conference. And today, we have Quest Diagnostics with us as our first presenter of the day.

I'm Brian Tanquilut, I'm the health care services analyst here at Jefferies. And joining us this morning is Steve Rusckowski, the CEO of Quest. And Shawn Bevec of Quest. He's Head of IR.

So Steve, thank you for doing this. Really appreciate you taking time today. I guess, oh yes, I'll just go jump straight into that, right?

Questions & Answers

Brian Gil Tanquilut;Stock Analyst
Jefferies LLC, Research Division - Senior Equity

/

So obviously, a lot of people are focused on -- or have been focused on COVID and your role there with COVID testing. But as things slowed down, I think the focus is starting to shift back to the core business. So just anything you can share with us in terms of what you're seeing with the ramp down of COVID

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot